Molecular Pharmacology (USA) Limited (OTC BB: MLPH) is pleased to announce the successful completion of the first meeting of it international scientific development team in Singapore on January 9th, 10th and 11th 2006. The symposium included MPL's United States, Australian and South East Asian drug development teams. The three-day forum focused on the interpretation of scientific data and clinical results achieved by the company in the fields of cellular inflammation, analgesic and secondary injury cascades.
